Multiple sclerosis life expectancy and prognosis

While MS isn’t fatal on its own, accompanying complications can shorten life. That said, treatment can significantly decrease the chance of a shortened life span. When it comes to the

outlook for multiple sclerosis (MS), there’s both good news and bad news. Although MS isn’t fatal, there’s currently no cure — MS is a chronic condition. But many people who have MS also

have to contend with other issues that can decrease their quality of life. Even though most will never become severely disabled, many experience symptoms that cause pain, discomfort, and

inconvenience. In this article, we’ll go over what to expect when it comes to MS. We’ll talk about outlook, and more. Is MS fatal? Complications associated with MS, like infections,

cardiovascular disease, and accidents, can cause the life span of someone with MS to be shorter than people who aren’t living with MS. But treating these complications can greatly reduce the

risk of a shortened life span. According to the National Multiple Sclerosis Society (NMSS), the life span of people with MS has increased over time. But the associated complications cause

the average life span with MS to be about 7 years shorter than people who don’t live with MS. Those with MS tend to die from many of the same conditions as people who don’t have the

condition, like cancer and heart disease. Apart from cases of severe MS, which are rare, the outlook for longevity is generally good. Outlook for MS Outlook is affected by the type of MS.

Primary progressive MS (PPMS) is characterized by a steady decline in function without significant relapses or remissions. Every case is different, so there may be some periods of inactive

decline. But the steady progression continues. For the relapsing forms of MS, several guidelines may help predict outlook. People with MS tend to do better if they experience: * few symptom

attacks in the initial few years post-diagnosis * a longer amount of time passing between attacks * a complete or almost complete recovery from their attacks * symptoms related exclusively

to sensory problems, like tingling, vision loss, or numbness * neurological exams that are almost normal 5 years after diagnosis MS isn’t a fatal condition in most cases, and most people

with MS have a close-to-normal life expectancy. But since the disease varies so much from person to person, it can be difficult for doctors to predict whether their condition will worsen or

improve. Another way of evaluating the outlook for MS is to examine how disabilities resulting from the condition’s symptoms may affect people. According to the NMSS, around two-thirds of

people with MS are able to walk without a wheelchair 2 decades after their diagnosis. Some people will need a cane or a walker to continue walking. Others use an electric scooter or

wheelchair to help them cope with fatigue or balance difficulties. »MORE:Join Bezzy, a free MS community. With Bezzy, you're never alone. MS progression and risk factors It’s hard to

predict how MS will progress in every person. The severity of the disease varies widely from person to person. * Around 45% of those with MS aren’t severely affected by the disease. * Most

people living with MS will undergo a certain amount of disease progression. To help determine your personal outlook, it helps to understand the risk factors that may indicate a greater

chance of developing a severe form of the condition. Certain factors indicate a higher risk for more severe symptoms, including the following: * You’re over 40 years at the initial onset of

symptoms. * Your initial symptoms affect many parts of your body. * Your initial symptoms affect mental functioning, urinary control, or motor control. MS outlook and what to expect MS

generally affects quality of life more than longevity. While certain types of MS can potentially affect life span, they are the exception — not the rule. People with MS must contend with

many difficult symptoms that will affect their lifestyle. But they can rest assured that with appropriate treatment of the disease, their life expectancy essentially mirrors that of people

who don’t have the condition. Read this article in Spanish.